Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Hyperactivity Disorder ◽

Laboratory Classroom ◽

Efficacy and Safety of Extended-Release Dexmethylphenidate Compared with d,l-Methylphenidate and Placebo in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A 12-Hour Laboratory Classroom Study

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2007.0015 ◽

2008 ◽

Vol 18 (3) ◽

pp. 248-256 ◽

Cited By ~ 27

Author(s):

Rafael Muniz ◽

Matthew Brams ◽

Alice Mao ◽

Kevin McCague ◽

L. Pestreich ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Hyperactivity Disorder ◽

Laboratory Classroom ◽

Faculty Opinions recommendation of Efficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: a 12-hour laboratory classroom study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120035.576161 ◽

2008 ◽

Author(s):

Robert Findling

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Hyperactivity Disorder ◽

Laboratory Classroom ◽

Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2020.0142 ◽

2021 ◽

Author(s):

Ann C. Childress ◽

Scott H. Kollins ◽

Andrew J. Cutler ◽

Andrea Marraffino ◽

Carolyn R. Sikes

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Dose Optimization ◽

Open Label ◽

Orally Disintegrating Tablet ◽

Hyperactivity Disorder ◽

Laboratory Classroom ◽

Label Dose ◽

The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2014.0176 ◽

2015 ◽

Vol 25 (5) ◽

pp. 402-414 ◽

Cited By ~ 14

Author(s):

Ann C. Childress ◽

Matthew Brams ◽

Andrew J. Cutler ◽

Scott H. Kollins ◽

Jo Northcutt ◽

...

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

Double Blind ◽

Hyperactivity Disorder ◽

Laboratory Classroom ◽

Classroom Study ◽

Amphetamine Sulfate

NWP06, an Extended-Release Oral Suspension of Methylphenidate, Improved Attention-Deficit/Hyperactivity Disorder Symptoms Compared with Placebo in a Laboratory Classroom Study

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2012.0073 ◽

2013 ◽

Vol 23 (1) ◽

pp. 3-10 ◽

Cited By ~ 26

Author(s):

Sharon B. Wigal ◽

Ann C. Childress ◽

Heidi W. Belden ◽

Sally A. Berry

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder ◽

Laboratory Classroom ◽

A Double-Blind, Randomized, Placebo/Active Controlled Crossover Evaluation of the Efficacy and Safety of Ritalin® LA in Children with Attention-Deficit/Hyperactivity Disorder in a Laboratory Classroom Setting

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2009.0106 ◽

2010 ◽

Vol 20 (5) ◽

pp. 377-385 ◽

Cited By ~ 9

Author(s):

Eberhard Schulz ◽

Christian Fleischhaker ◽

Klaus Hennighausen ◽

Philip Heiser ◽

Klaus-Uwe Oehler ◽

...

Keyword(s):

Attention Deficit ◽

Classroom Setting ◽

Efficacy And Safety ◽

Double Blind ◽

Hyperactivity Disorder ◽

Laboratory Classroom

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.218 ◽

2016 ◽

Vol 55 (10) ◽

pp. S170

Author(s):

Valerie K. Arnold ◽

Norberto J. DeSousa ◽

Bev Incledon ◽

Floyd R. Sallee ◽

Timothy E. Wilens ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Pivotal Phase ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder ◽

Delayed Release

A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.05.021 ◽

2020 ◽

Vol 42 (8) ◽

pp. 1452-1466 ◽

Cited By ~ 2

Author(s):

Azmi Nasser ◽

Tesfaye Liranso ◽

Toyin Adewole ◽

Nicholas Fry ◽

Joseph T. Hull ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Controlled Trial ◽

Phase Iii ◽

School Age Children ◽

School Age ◽

Efficacy And Safety ◽

Once Daily ◽

Hyperactivity Disorder

Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison

European Child & Adolescent Psychiatry ◽

10.1007/s00787-017-0962-6 ◽

2017 ◽

Vol 26 (8) ◽

pp. 875-897 ◽

Cited By ~ 13

Author(s):

Alain Joseph ◽

Rajeev Ayyagari ◽

Meng Xie ◽

Sean Cai ◽

Jipan Xie ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Mixed Treatment Comparison ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Hyperactivity Disorder ◽

Treatment Comparison ◽

Mixed Treatment

6.9 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2017.09.354 ◽

2017 ◽

Vol 56 (10) ◽

pp. S278-S279

Author(s):

Ann Childress ◽

Sally Berry ◽

Antonio Pardo ◽

Heidi W. Belden

Keyword(s):

Pilot Study ◽

Attention Deficit ◽

Early Onset ◽

Extended Release ◽

Oral Suspension ◽

Efficacy And Safety ◽

Hyperactivity Disorder